The effect of safinamide, a novel drug for Parkinson's disease, on pressor response to oral tyramine: a randomized, double-blind, clinical trial.
about
Adjuvant therapies for Parkinson's disease: critical evaluation of safinamideFormulary Drug Review: Safinamide.Body fat reduction without cardiovascular alteration in mice under oral treatment by the MAO inhibitor phenelzine.Safinamide in the management of patients with Parkinson's disease not stabilized on levodopa: a review of the current clinical evidence
P2860
The effect of safinamide, a novel drug for Parkinson's disease, on pressor response to oral tyramine: a randomized, double-blind, clinical trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The effect of safinamide, a no ...... double-blind, clinical trial.
@en
The effect of safinamide, a no ...... double-blind, clinical trial.
@nl
type
label
The effect of safinamide, a no ...... double-blind, clinical trial.
@en
The effect of safinamide, a no ...... double-blind, clinical trial.
@nl
prefLabel
The effect of safinamide, a no ...... double-blind, clinical trial.
@en
The effect of safinamide, a no ...... double-blind, clinical trial.
@nl
P2093
P2860
P356
P1476
The effect of safinamide, a no ...... double-blind, clinical trial.
@en
P2093
P2860
P304
P356
10.1038/CLPT.2012.128
P407
P577
2012-09-05T00:00:00Z